ArticleWorld journal of nuclear medicine2022

Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma.

Enrique Cadena-Piñeros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.